RT Journal Article
SR Electronic
T1 Alzheimer’s Disease Classification Using 2D Convolutional Neural Networks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.24.21257554
DO 10.1101/2021.05.24.21257554
A1 Gongbo Liang
A1 Xin Xing
A1 Liangliang Liu
A1 Qi Ying
A1 Ai-Ling Lin
A1 Nathan Jacobs
YR 2021
UL http://medrxiv.org/content/early/2021/06/03/2021.05.24.21257554.abstract
AB Alzheimer’s disease (AD) is a non-treatable and non-reversible disease that affects about 6% of people who are 65 and older. Brain magnetic resonance imaging (MRI) is a pseudo-3D imaging modality that is widely used for AD diagnosis. Convolutional neural networks with 3D kernels (3D CNNs) are often the default choice for deep learning based MRI analysis. However, 3D CNNs are usually computationally costly and data-hungry. Such disadvantages post a barrier of using modern deep learning techniques in the medical imaging domain, in which the number of data can be used for training is usually limited. In this work, we propose three approaches that leverage 2D CNNs on 3D MRI data. We test the proposed methods on the Alzheimer’s Disease Neuroimaging Initiative dataset across two popular 2D CNN architectures. The evaluation results show that the proposed method improves the model performance on AD diagnosis by 8.33% accuracy or 10.11% auROC, while significantly reduce the training time by over 89%. We also discuss the potential causes for performance improvement and the limitation. We believe this work can serve as a strong baseline for future researchers.Competing Interest StatementThe authors have declared no competing interest.Funding Statementn/aAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB is exemption for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study is from The Alzheimer's Disease Neuroimaging Initiative (ADNI) (http://adni.loni.usc.edu)